Want to join the conversation?
$FSLR narrowed its 2016 net sales guidance to $3.8-4Bil from the previous forecast of $3.9-4.1Bil and raised lower end of GM guidance to 17-18% from the prior guidance of 16-18%. Operating cash flow guidance is narrowed to $400-600MM form $500-700MM. The company still expects 2016 EPS between $4-4.50, CapEX of $300-400MM and shipments of 2.9-3GW.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?